Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma

Journal of Urology

Volumn 170, Issue 2 I, 2003, Pages 420-424

  Parker, Alexander S ^a   Cheville, John C ^a   Lohse, Christine ^a   Cerhan, James R ^a   Blute, Michael L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Carcinoma, renal cell; Kidney; Nephrectomy; Receptors, somatomedin; Survival rate

Indexed keywords

SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; DISEASE MARKER; DRUG TARGETING; FEMALE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR UPREGULATION; RISK ASSESSMENT; SCORING SYSTEM; TISSUE NECROSIS;

EID: 0038491208     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000071474.70103.92     Document Type: Article

References (20)

1. Chow, W.-H., Devesa, S. S. and Fraumeni, J. F., Jr.: Epidemiology of renal carcinoma. In: Comprehensive Textbook of Genitourinary Oncology, 2nd ed. Edited by N. J. Vogelzang, W. U. Shipley, P. T. Scardino and D. S. Coffey. Philadelphia: Lippincott, Williams and Wilkins, pp. 101-110, 2000
2. Frank, I., Blute, M. L., Cheville, J. C., Lohse, C. M., Weaver, A. L. and Zincke, H.: An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol, 168: 2395, 2002
3. Baserga, R., Hongo, A., Rubini, M. and Valentinis, B.: The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta, 1332: F105, 1997
4. Holly, J. M., Gunnell, D. J., and Davey Smith, G.: Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J Endocrinol, 162: 321, 1999
5. Grimberg, A. and Cohen, P.: Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol, 183: 1, 2000
6. Kellerer, M., von Eye Corleta, H., Muhlhofer, A., Capp, E., Mosthaf, L., Bock, S. et al: Insulin- and insulin-like growth-factor-I receptor tyrosine-kinase activities in human renal carcinoma. Int J Cancer, 62: 501, 1995
7. Datta, K., Nambudripad, R., Pal, S., Zhou, M., Cohen, H. T. and Mukhopadhyay, D.: Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer. J Biol Chem, 275: 20700, 2000
8. Amin, M. B., Amin, M. B., Tamboli, P., Javidan, J., Stricker, H., de-Peralta Venturina, M. et al: Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol, 26: 281, 2002
9. Lohse, C. M., Blute, M. L., Zincke, H., Weaver, A. L. and Cheville, J. C.: Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients. Am J Clin Pathol, 118: 877, 2002
10. Guinan, P., Sobin, L. H., Algaba, F., Badellino, F., Kameyama, S., MacLennan, G. et al: TNM staging of renal cell carcinoma: Workgroup No 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) Cancer, 80: 992, 1997
11. Cox, D. R.: Regression models and life-tables. J Roy Stat Soc, 34: 187, 1972
12. Grothey, A., Voigt, W., Schober, C., Muller, T., Dempke, W. and Schmoll, H. J.: The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors. J Cancer Res Clin Oncol, 125: 166, 1999
13. Werner, H.: Dysregulation of the type 1IGF receptor as a paradigm in tumor progression. Mol Cell Endocrinol, 141: 1, 1998
14. O'Conner, R., Fennelly, C. and Krause, D.: Regulation of survival signals from the insulin-like growth factor-I receptor. Biochem Soc Trans, 28: 47, 2000
15. Lee, C. T., Wu, S., Gabrilovich, D., Chen, H., Nadaf-Rahrov, S., Ciernik, I. F. et al: Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Cancer Res, 56: 3038, 1996
16. Prager, D., Li, H. L., Asa, S. and Melmed, S.: Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci USA, 91: 2181, 1994
17. Parker, A. S., Cheville, J. C., Janney, C. A. and Cerhan, J. R.: High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas. Hum Pathol, 33: 801, 2002
18. Datta, K., Sunberg, C., Karumanchi, S. A. and Mukhopadhyay, D.: The 104-123 amino acid sequence of the beta-domain of the von Hippel-Lindau gene product is sufficient to inhibit renal tumor growth and invasion. Cancer Res, 61: 1768, 2001
19. Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H. et al: Mutations of the VHL tumor suppressor gene in renal carcinoma. Nat Genet, 7: 85, 1994
20. Weinstein, M. H. and Dal Cin, P.: Genetics of epithelial tumors of the renal parenchyma in adults and renal cell carcinoma in children. Anal Quant Cytol Histol, 23: 362, 2001